Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy

Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy

Abstract Background A substantial number of patients will develop further biochemical progression after radical prostatectomy (RP) and salvage radiotherapy (sRT). Recently published data using prostate-specific membrane antigen ligand positron emission tomography (PSMA - PET) for re-staging suggest...

Full description

Bibliographic Details
Main Authors: Ann-Kathrin Oehus, Stephanie G. C. Kroeze, Nina-Sophie Schmidt-Hegemann, Marco M. E. Vogel, Simon Kirste, Jessica Becker, Irene A. Burger, Thorsten Derlin, Peter Bartenstein, Matthias Eiber, Michael Mix, Christian la Fougère, Claus Belka, Stephanie E. Combs, Anca-Ligia Grosu, Arndt-Christian Müller, Matthias Guckenberger, Hans Christiansen, Christoph Henkenberens
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Cancer
Subjects:
PSMA
Radiotherapy
Prostate cancer
Oligometastases
Recurrence
Radical prostatectomy
Online Access:http://link.springer.com/article/10.1186/s12885-020-06883-5

Internet

http://link.springer.com/article/10.1186/s12885-020-06883-5

Similar Items